For those suffering from an array of medical conditions, cannabis has proven to be an effective medicine. Despite this fact, cannabis has remained a Schedule I substance, meaning the federal government believes it has no medical value whatsoever. This scheduling continues to limit studies on marijuana-based cannabinoids, leaving patients hopeful for treatment to experiment with what dosing works best. While there are many studies on tetrahydrocannabinol (THC), studies on the other cannabinoids — of which at least 85 have been discovered — remain limited. Most notable in regards to its recent upsurge in popularity is the lack of studies relating to cannabidiol (CBD).
According to Jahan Marcu, senior science advisor with Americans for Safe Access (ASA), studies on CBD have primarily been conducted with either 1-to-1 THC-to-CBD ratios or high THC and low CBD dosing. These studies, which include examinations of human cancer cell lines, experiments on human tissue and studies with human subjects, have shown many benefits associated with CBD, Marcu says.
California-based Care by Design has released a product line that allows patients to test CBD in different ratios to find which dose is most effective for treating their particular condition. The Care by Design sprays range from a 1-to-1 ratio of CBD-to-THC all the way up to an 18-to-1 ratio. These sprays, which utilize coconut oil as a base and can include mint essential oil for taste, can be used as a topical or ingested orally.
The C02-extracted oils are convenient in that each spray offers a measured dose, there are approximately 30 sprays in a 5ml bottle and 90 sprays in a 15ml bottle. Care by Design grows the cannabis featured in each product and lab tests each to ensure the highest quality of medicine. The company says the 1-to-1 ratio spray, designated by a red-branded bottle, is best in terms of pain relief. Care by Design recommends moderate doses of a CBD-dominant spray with little THC, such as its 18-to-1 CBD-to-THC ratio, for those who suffer from conditions such as anxiety, depression, spasms and pediatric seizure disorders.
“CBD can inhibit the enzymes that synthesize and breakdown endocannabinoids and that can allow THC to synergize with other endocannabinoids,” Marcu said of the modulation effects present in CBD during an ASA presentation earlier this year.
In addition, Marcu explains that CBD has it’s own unique anti-inflammatory process and can prime cannabinoid receptors for activation, an important factor for the pain relief associated with cannabis consumption.
The oils are pleasant whether used topically or ingested. With the wide array of dosing options available, those seeking to harness the healing powers of cannabis can start with Care by Design as a way to truly personalize their treatment.
Do you use a topical treatment to relieve you symptoms? Tell us about your experience below.